Published by Michele Maatouk on 23rd June 2022
(Sharecast News) - GlaxoSmithKline said on Thursday it will invest £1bn over ten years to accelerate research and development (R&D) into infectious diseases that disproportionately impact lower-income countries.
URL: http://www.digitallook.com/dl/news/story/32771995/...